Ginkgo Bioworks Holdings Inc DNA
$7.40 $0.44 (6.32%) 1D
Last Updated: Aug 21, 12:00 AM·NYSE
Pricing for US stocks is delayed by 24 hours
DNA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Ginkgo Bioworks Holdings Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Ginkgo Bioworks Holdings Inc. Stock Analysis DNA
United States Health Care Small Cap Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. The company is headquartered in Boston, Massachusetts and currently employs 485 full-time employees. The company went IPO on 2021-04-19. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The firm provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.
Ginkgo Bioworks Holdings Inc (DNA) Chart
Financial Metrics & Statements of Ginkgo Bioworks Holdings Inc (DNA)
FAQ's for Ginkgo Bioworks Holdings Inc (DNA)
- As of August 2026, Ginkgo Bioworks Holdings Inc DNA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ginkgo Bioworks Holdings Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Ginkgo Bioworks Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Ginkgo Bioworks Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Ginkgo Bioworks Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Ginkgo Bioworks Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Ginkgo Bioworks Holdings Inc (DNA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
